Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.2 Market Definition
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources & Third Party perspectives
1.3.4 Primary Research
1.4 Information Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Data Visualization
1.6 Data Validation & Publishing
Chapter 2 Executive Summary
2.1 Alopecia Market Outlook, By Revenue (USD Million)
2.2 Alopecia Segment Outlook, By Revenue (USD Million)
2.3 Competititve Insights
Chapter 3 Alopecia Market Variables, Trends and Scope
3.1 Penetration & Growth Prospect Mapping
3.2 Product Pipeline Analysis, by Stage
3.3 Industry Value Chain Analysis
3.3.1 User Perspective Analysis
3.3.1.1 Consumer behaviour analysis
3.3.1.2 Market influencer analysis
3.3.2 Cost structure analysis
3.4 Market Dynamics
3.4.1 Market driver analysis
3.4.1.1 Increasing prevalance of alopecia
3.4.1.2 Increasing prevalence of healthcare expensitures
3.4.1.3 Increasing prevalence of chronic diseases
3.4.1.3.1 PCOS
3.4.1.3.2 Cancer
3.4.1.3.3 Rheumatoid Arthritis
3.4.1.4 Technological advancements in alopecia treatment
3.4.2 Market restraint analysis
3.4.2.1 Lack of reimbursement policies for alopecia treatment
3.4.3 Industry challenges
3.5 Alopecia Market Analysis Tools
3.5.1 Industry analysis – Porter’s
3.5.1.1 Supplier power
3.5.1.2 Buyer power
3.5.1.3 Substitution threat
3.5.1.4 New entrants threat
3.5.1.5 Competitive rivalry
3.5.2 PESTEL Analysis
3.5.2.1 Political landscape
3.5.2.2 Economic landscape
3.5.2.3 Social landscape
3.5.2.4 Technology landscape
3.5.3 Major deals and strategic alliances analysis
3.5.4 Market entry strategies
Chapter 4 Alopecia Market – Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company/Competition Categorization
4.3 Public Companies
4.3.1 Company Market Position Analysis
4.3.2 Company Market Share/Ranking, by Region
4.4 Private Companies
4.4.1 List of Key Emerging Companies/Technology Disruptors/Innovators
4.4.2 Regional Network Map
4.4.3 Company Market Position Analysis
4.4.4 Supplier Ranking
Chapter 5 Alopecia Market: Disease Type Estimates & Trend Analysis
5.1 Definitions & Scope
5.2 Alopecia Market Share by Disease Type, 2018 & 2025
5.3 Segment Dashboard
5.4 Alopecia Areata
5.4.1 Alopecia areata market estimates and forecasts, 2014 – 2025 (USD Million)
5.4.2 Alopecia areata market estimates and forecasts, by gender, 2014 – 2025 (USD Million)
5.5 Androgenetic Alopecia
5.5.1 Androgenetic alopecia market estimates and forecasts, 2014 – 2025 (USD Million)
5.5.2 Androgentic alopecia market estimates and forecasts, by gender, 2014 – 2025 (USD Million)
5.6 Others
5.6.1 Other alopecia diseases market estimates and forecasts, 2014 – 2025 (USD Million)
5.6.2 Other alopecia diseases market estimates and forecasts, 2014 – 2025, by gender (USD Million)
Chapter 6 Alopecia Market: End Use Estimates & Trend Analysis
6.1 Definitions & Scope
6.2 Alopecia Market Share by End Use, 2018 & 2025
6.3 Segment Dashboard
6.4 Homecare Settings
6.4.1 Homecare settings market estimates and forecasts, 2014 – 2025 (USD Million)
6.5 Dermatology Clinics
6.5.1 Dermatology clinics market estimates and forecasts, 2014 – 2025 (USD Million)
Chapter 7 Alopecia Market: Sales Channel Estimates & Trend Analysis
7.1 Definitions & Scope
7.2 Alopecia Market Share by Sales channel, 2018 & 2025
7.3 Segment Dashboard
7.4 Prescriptions
7.4.1 Prescriptions market estimates and forecasts, 2014 – 2025 (USD Million)
7.5 OTC
7.5.1 OTC market estimates and forecasts, 2014 – 2025 (USD Million)
Chapter 8 Alopecia Market: Gender Estimates & Trend Analysis
8.1 Definitions & Scope
8.2 Alopecia Market Share by Gender, 2018 & 2025
8.3 Segment Dashboard
8.4 Male
8.4.1 Male alopecia market estimates and forecasts, 2014 – 2025 (USD Million)
8.5 Female
8.5.1 Female alopecia market estimates and forecasts, 2014 – 2025 (USD Million)
Chapter 9 Alopecia Market: Regional Estimates & Trend Analysis, by Product
9.1 Regional Market Snapshot
9.2 Regional Market Share and Leading Players, 2018
9.2.1 North America
9.2.2 Europe
9.2.3 Asia Pacific
9.2.4 Latin America
9.2.5 Middle East & Africa
9.3 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
9.3.1 North America
9.3.2 Europe
9.3.3 Asia Pacifc
9.3.4 Latin America
9.4.5 Middle East & Africa
9.4 Market Size, & Forecasts, and Trend Analysis, 2018 to 2025:
9.4.1 North America
9.4.1.1 Market estimates and forecasts, by disease type 2014 – 2025 (USD Million)
9.4.1.2 Market estimates and forecasts, by end use 2014 – 2025 (USD Million)
9.4.1.3 Market estimates and forecasts, by sales channel 2014 – 2025 (USD Million)
9.4.1.4 Market estimates and forecasts, by gender 2014 – 2025 (USD Million)
9.4.1.5 U.S.
9.4.1.5.1 Market estimates and forecasts, by disease type 2014 – 2025 (USD Million)
9.4.1.5.2 Market estimates and forecasts, by end use 2014 – 2025 (USD Million)
9.4.1.5.3 Market estimates and forecasts, by sales channel 2014 – 2025 (USD Million)
9.4.1.5.4 Market estimates and forecasts, by gender 2014 – 2025 (USD Million)
9.4.1.6 Canada
9.4.1.6.1 Market estimates and forecasts, by disease type 2014 – 2025 (USD Million)
9.4.1.6.2 Market estimates and forecasts, by end use 2014 – 2025 (USD Million)
9.4.1.6.3 Market estimates and forecasts, by sales channel 2014 – 2025 (USD Million)
9.4.1.6.4 Market estimates and forecasts, by gender 2014 – 2025 (USD Million)
9.4.2 Europe
9.4.2.1 Market estimates and forecasts, by disease type 2014 – 2025 (USD Million)
9.4.2.2 Market estimates and forecasts, by end use 2014 – 2025 (USD Million)
9.4.2.3 Market estimates and forecasts, by sales channel 2014 – 2025 (USD Million)
9.4.2.3.1 Market estimates and forecasts, by gender 2014 – 2025 (USD Million)
9.4.2.4 U.K.
9.4.2.4.1 Market estimates and forecasts, by disease type 2014 – 2025 (USD Million)
9.4.2.4.2 Market estimates and forecasts, by end use 2014 – 2025 (USD Million)
9.4.2.4.3 Market estimates and forecasts, by sales channel 2014 – 2025 (USD Million)
9.4.1.4.4 Market estimates and forecasts, by gender 2014 – 2025 (USD Million)
9.4.2.5 Germany
9.4.2.5.1 Market estimates and forecasts, by disease type 2014 – 2025 (USD Million)
9.4.2.5.2 Market estimates and forecasts, by end use 2014 – 2025 (USD Million)
9.4.2.5.3 Market estimates and forecasts, by sales channel 2014 – 2025 (USD Million)
9.4.1.4.4 Market estimates and forecasts, by gender 2014 – 2025 (USD Million)
9.4.2.6 Spain
9.4.2.6.1 Market estimates and forecasts, by disease type 2014 – 2025 (USD Million)
9.4.2.6.2 Market estimates and forecasts, by end use 2014 – 2025 (USD Million)
9.4.2.6.3 Market estimates and forecasts, by sales channel 2014 – 2025 (USD Million)
9.4.1.4.4 Market estimates and forecasts, by gender 2014 – 2025 (USD Million)
9.4.2.7 France
9.4.2.7.1 Market estimates and forecasts, by disease type 2014 – 2025 (USD Million)
9.4.2.7.2 Market estimates and forecasts, by end use 2014 – 2025 (USD Million)
9.4.2.7.3 Market estimates and forecasts, by sales channel 2014 – 2025 (USD Million)
9.4.1.4.4 Market estimates and forecasts, by gender 2014 – 2025 (USD Million)
9.4.2.8 Italy
9.4.2.8.1 Market estimates and forecasts, by disease type 2014 – 2025 (USD Million)
9.4.2.8.2 Market estimates and forecasts, by end use 2014 – 2025 (USD Million)
9.4.2.8.3 Market estimates and forecasts, by sales channel 2014 – 2025 (USD Million)
9.4.1.4.4 Market estimates and forecasts, by gender 2014 – 2025 (USD Million)
9.4.2.9 Russia
9.4.2.9.1 Market estimates and forecasts, by disease type 2014 – 2025 (USD Million)
9.4.2.9.2 Market estimates and forecasts, by end use 2014 – 2025 (USD Million)
9.4.2.9.3 Market estimates and forecasts, by sales channel 2014 – 2025 (USD Million)
9.4.1.4.4 Market estimates and forecasts, by gender 2014 – 2025 (USD Million)
9.4.3 Asia Pacific
9.4.3.1 Market estimates and forecasts, by disease type 2014 – 2025 (USD Million)
9.4.3.2 Market estimates and forecasts, by end use 2014 – 2025 (USD Million)
9.4.3.3 Market estimates and forecasts, by sales channel 2014 – 2025 (USD Million)
9.4.3.4 Market estimates and forecasts, by gender 2014 – 2025 (USD Million)
9.4.3.5 China
9.4.3.5.1 Market estimates and forecasts, by disease type 2014 – 2025 (USD Million)
9.4.3.5.2 Market estimates and forecasts, by end use 2014 – 2025 (USD Million)
9.4.3.5.3 Market estimates and forecasts, by sales channel 2014 – 2025 (USD Million)
9.4.3.5.4 Market estimates and forecasts, by gender 2014 – 2025 (USD Million)
9.4.3.6 Japan
9.4.3.6.1 Market estimates and forecasts, by disease type 2014 – 2025 (USD Million)
9.4.3.6.2 Market estimates and forecasts, by end use 2014 – 2025 (USD Million)
9.4.3.6.3 Market estimates and forecasts, by sales channel 2014 – 2025 (USD Million)
9.4.3.6.4 Market estimates and forecasts, by gender 2014 – 2025 (USD Million)
9.4.3.7 India
9.4.3.7.1 Market estimates and forecasts, by disease type 2014 – 2025 (USD Million)
9.4.3.7.2 Market estimates and forecasts, by end use 2014 – 2025 (USD Million)
9.4.3.7.3 Market estimates and forecasts, by sales channel 2014 – 2025 (USD Million)
9.4.3.7.4 Market estimates and forecasts, by gender 2014 – 2025 (USD Million)
9.4.3.8 South Korea
9.4.3.8.1 Market estimates and forecasts, by disease type 2014 – 2025 (USD Million)
9.4.3.8.2 Market estimates and forecasts, by end use 2014 – 2025 (USD Million)
9.4.3.8.3 Market estimates and forecasts, by sales channel 2014 – 2025 (USD Million)
9.4.3.8.4 Market estimates and forecasts, by gender 2014 – 2025 (USD Million)
9.4.3.9 Singapore
9.4.3.9.1 Market estimates and forecasts, by disease type 2014 – 2025 (USD Million)
9.4.3.9.2 Market estimates and forecasts, by end use 2014 – 2025 (USD Million)
9.4.3.9.3 Market estimates and forecasts, by sales channel 2014 – 2025 (USD Million)
9.4.3.9.4 Market estimates and forecasts, by gender 2014 – 2025 (USD Million)
9.4.3.10 Australia
9.4.3.10.1 Market estimates and forecasts, by disease type 2014 – 2025 (USD Million)
9.4.3.10.2 Market estimates and forecasts, by end use 2014 – 2025 (USD Million)
9.4.3.10.3 Market estimates and forecasts, by sales channel 2014 – 2025 (USD Million)
9.4.3.10.4 Market estimates and forecasts, by gender 2014 – 2025 (USD Million)
9.4.4 Latin America
9.4.4.1 Market estimates and forecasts, by disease type 2014 – 2025 (USD Million)
9.4.4.2 Market estimates and forecasts, by end use 2014 – 2025 (USD Million)
9.4.4.3 Market estimates and forecasts, by sales channel 2014 – 2025 (USD Million)
9.4.4.4 Market estimates and forecasts, by gender 2014 – 2025 (USD Million)
9.4.4.5 Brazil
9.4.4.5.1 Market estimates and forecasts, by disease type 2014 – 2025 (USD Million)
9.4.4.5.2 Market estimates and forecasts, by end use 2014 – 2025 (USD Million)
9.4.4.5.3 Market estimates and forecasts, by sales channel 2014 – 2025 (USD Million)
9.4.4.5.4 Market estimates and forecasts, by gender 2014 – 2025 (USD Million)
9.4.4.6 Mexico
9.4.4.6.1 Market estimates and forecasts, by disease type 2014 – 2025 (USD Million)
9.4.4.6.2 Market estimates and forecasts, by end use 2014 – 2025 (USD Million)
9.4.4.6.3 Market estimates and forecasts, by sales channel 2014 – 2025 (USD Million)
9.4.4.6.4 Market estimates and forecasts, by gender 2014 – 2025 (USD Million)
9.4.4.7 Argentina
9.4.4.7.1 Market estimates and forecasts, by disease type 2014 – 2025 (USD Million)
9.4.4.7.2 Market estimates and forecasts, by end use 2014 – 2025 (USD Million)
9.4.4.7.3 Market estimates and forecasts, by sales channel 2014 – 2025 (USD Million)
9.4.4.7.4 Market estimates and forecasts, by gender 2014 – 2025 (USD Million)
9.4.5 Middle East & Africa (MEA)
9.4.5.1 Market estimates and forecasts, by disease type 2014 – 2025 (USD Million)
9.4.5.2 Market estimates and forecasts, by end use 2014 – 2025 (USD Million)
9.4.5.3 Market estimates and forecasts, by sales channel 2014 – 2025 (USD Million)
9.4.5.4 Market estimates and forecasts, by gender 2014 – 2025 (USD Million)
9.4.5.5 South Africa
9.4.5.5.1 Market estimates and forecasts, by disease type 2014 – 2025 (USD Million)
9.4.5.5.2 Market estimates and forecasts, by end use 2014 – 2025 (USD Million)
9.4.5.5.3 Market estimates and forecasts, by sales channel 2014 – 2025 (USD Million)
9.4.5.5.4 Market estimates and forecasts, by gender 2014 – 2025 (USD Million)
9.4.5.6 Saudi Arabia
9.4.5.6.1 Market estimates and forecasts, by disease type 2014 – 2025 (USD Million)
9.4.5.6.2 Market estimates and forecasts, by end use 2014 – 2025 (USD Million)
9.4.5.6.3 Market estimates and forecasts, by sales channel 2014 – 2025 (USD Million)
9.4.5.6.4 Market estimates and forecasts, by gender 2014 – 2025 (USD Million)
9.4.5.7 UAE
9.4.5.7.1 Market estimates and forecasts, by disease type 2014 – 2025 (USD Million)
9.4.5.7.2 Market estimates and forecasts, by End use 2014 – 2025 (USD Million)
9.4.5.7.3 Market estimates and forecasts, by sales channel 2014 – 2025 (USD Million)
9.4.5.7.4 Market estimates and forecasts, by gender 2014 – 2025 (USD Million)
Chapter 10 Competitive Landscape
10.1 Company Profiles
10.1.1 Cipla, Inc.
10.1.1.1 Company Overview
10.1.1.2 Financial Performance
10.1.1.3 Product Benchmarking
10.1.1.4 Strategic Initiatives
10.1.2 Sun Pharmaceuticals Industries Ltd.
10.1.2.1 Company Overview
10.1.2.2 Financial Performance
10.1.2.3 Product Benchmarking
10.1.2.4 Strategic Initiatives
10.1.3 Johnson & Johnson Services, Inc.
10.1.3.1 Company Overview
10.1.3.2 Financial Performance
10.1.3.3 Product Benchmarking
10.1.3.3 Strategic Initiatives
10.1.4 Merck & Co., Inc.
10.1.4.1 Company Overview
10.1.4.2 Financial Performance
10.1.4.3 Product Benchmarking
10.1.4.4 Strategic Initiatives
10.1.5 Lexington International LLC
10.1.5.1 Company Overview
10.1.5.2 Financial Performance
10.1.5.3 Product Benchmarking
10.1.5.4 Strategic Initiatives
10.1.6 Cirrus Hair Centers
10.1.6.1 Company Overview
10.1.6.2 Financial Performance
10.1.6.3 Product Benchmarking
10.1.6.4 Strategic Initiatives
10.1.7 Vita-Cos-Med Klett-Loch GmbH
10.1.7.1 Company Overview
10.1.7.2 Financial Performance
10.1.7.3 Product Benchmarking
10.1.7.4 Strategic Initiatives
10.1.8 Transitions Hair Pty Ltd.
10.1.8.1 Company Overview
10.1.8.2 Financial Performance
10.1.8.3 Product Benchmarking
10.1.8.4 Strategic Initiatives
10.1.9 Follica, Inc.
10.1.9.1 Company Overview
10.1.9.2 Financial Performance
10.1.9.3 Product Benchmarking
10.1.9.4 Strategic Initiatives
10.1.10 Capillus
10.1.10.1 Company Overview
10.1.10.2 Financial Performance
10.1.10.3 Product Benchmarking
10.1.10.4 Strategic Initiatives
10.2 List of Other Manufacturers
【掲載企業】
Cipla, Inc., Sun Pharmaceuticals Industries Ltd., Johnson & Johnson Services, Inc., Merck & Co., Inc., Lexington International LLC, Cirrus Hair Centers, Vita-Cos-Med Klett-Loch GmbH, Transitions Hair Pty Ltd., Follica, Inc., Capillus
【免責事項】
https://www.globalresearch.jp/disclaimer